Search
for
Sort by
Research 751–780 of 1000+
- Circulating monocytes as a marker of response to adalimumab in patients with hidradenitis suppurativa: A single institution, real-world cohort study
- A retrospective clinical and laboratory analysis including vitamin D and antinuclear antibodies in central centrifugal cicatricial alopecia and nonscarring alopecia in African Americans
- Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study
- Improving efficacy and maintaining safety in the treatment of alopecia with low-dose oral minoxidil and spironolactone combination therapy: A retrospective review
- A New Method for the Follow-Up of Patients with Alopecia Areata
- Drug-induced scarring and permanent alopecia
- Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies
- A cross-sectional observational study showing sebaceous glands differences between psoriatic alopecia and alopecia areata
- The prevalence of skin diseases in Greece, impact on quality of life and stigmatization: A population‐based survey study
- Cannabinoids for the Treatment of Hair, Scalp, and Skin Disorders: A Systematic Review
- Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgroup Analyses of US Pivotal Clinical Data
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Economic burden of alopecia areata: A study of direct and indirect cost in Japan using real‐world data
- Janus kinase inhibitors for alopecia areata: A narrative review
- A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants
- Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
- Alopecia areata – Aktuelles Verständnis und Management
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- The COVID-19 pandemic and its skin effects
- Association of resilience and perceived stress in patients with alopecia areata: A cross-sectional study
- Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment
- Two cases in which tofacitinib effectively treated both ulcerative colitis and alopecia areata
- Moisturizers, Lubricants, and Vulvar Hygiene Products: Issues, Answers, and Clinical Implications
- Experts’ view on the management of scalp seborrheic dermatitis in Italy
- Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study
- Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast Cancer
- Improvement in Patient‐Reported Emotional Symptoms and Activity Limitations due to Hair Loss in Patients With Alopecia Areata Treated With Ritlecitinib: Additional Analyses From ALLEGRO ‐2b/3